What is NDC 82954-0100?

82954-0100 is the product NDC for RiVive (naloxone hydrochloride), Naloxone hydrochloride 3 mg/.1mL spray, listed with the FDA by Harm Reduction Therapeutics, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

RiVive (Naloxone hydrochloride).

Harm Reduction Therapeutics, Inc., NDC labeler code 82954. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for RiVive?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

RiVive NDC 82954-0100 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)82954-0100Labeler and product segments. Claims need a package NDC.

Product NDC at billing width82954-0100Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
82954-0100-1	82954010001	2 VIAL, SINGLE-DOSE in 1 CARTON (82954-0100-1) / .1 mL in 1 VIAL, SINGLE-DOSEMarketed from Jan 2, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): RiVive
Generic name (nonproprietary): naloxone hydrochloride
Active ingredients: Naloxone hydrochloride — 3 mg/.1mL
Dosage form: Spray
Route: Nasal
Labeler: Harm Reduction Therapeutics, Inc.NDC labeler code 82954
Product type: Over-the-counter drug
Marketing category: NDA — New Drug ApplicationApplication NDA 217722
Marketing start: Jan 2, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Opioid Antagonists (Mechanism)
Identifiers: Product ID 82954-0100_4e308ade-33a2-4daa-acdd-af1559b90c17SPL ID 4e308ade-33a2-4daa-acdd-af1559b90c17SPL set ID 1c4f1b9d-1c70-4666-a90e-2f5d2c670d4dRxCUI 2673091UNII F850569PQR
Pharmacologic class: Opioid Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Nasal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482954010001 followed by a unit qualifier and the quantity

Package 82954-0100-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 13, 2026.

Indications (excerpt from the label)

Uses • to “revive” someone during an overdose from many prescription pain medications or street drugs such as heroin • this medicine can save a life

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 82954-0100

What is NDC 82954-0100?: 82954-0100 is the product NDC for RiVive (naloxone hydrochloride), Naloxone hydrochloride 3 mg/.1mL spray, listed with the FDA by Harm Reduction Therapeutics, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: RiVive (Naloxone hydrochloride).
What is the active ingredient?: Naloxone hydrochloride.
Who is the labeler?: Harm Reduction Therapeutics, Inc., NDC labeler code 82954. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for RiVive?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

RiVive (Naloxone hydrochloride) NDC 82954-0100